Kindeva Drug Delivery, a global CDMO, has successfully completed its first registration batch on its groninger high-volume vial line at its state-of-the-art Bridgeton, MO facility, marking the facility’s readiness to provide injectable fill-finish capabilities.   Denis Johnson, Chief Operating Officer at Kindeva, said, “The completion of the first registration batch at the Bridgeton facility represents a significant milestone. This is the first of four lines planned to be installed in the next...